# Matinas Biopharma Holdings Inc. (MTNB) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2023 | -$24M |
| 2022 | -$25M |
| 2021 | -$25M |
| 2020 | -$24M |
| 2019 | -$19M |
| 2018 | -$15M |
| 2017 | -$17M |
| 2016 | -$8M |
| 2015 | -$10M |
| 2014 | -$10M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2023-03-31 | -$6M |
| 2022-09-30 | -$5M |
| 2022-06-30 | -$6M |
| 2021-03-31 | -$6M |
| 2020-09-30 | -$6M |
| 2019-06-30 | -$5M |
| 2018-06-30 | -$3M |
| 2018-03-31 | -$4M |
| 2017-09-30 | -$3M |
| 2017-06-30 | -$4M |
| 2017-03-31 | -$4M |
| 2016-09-30 | -$2M |
| 2016-06-30 | -$2M |
| 2016-03-31 | -$2M |
| 2015-09-30 | -$2M |
| 2015-06-30 | -$2M |
| 2015-03-31 | -$3M |
| 2014-09-30 | -$3M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/MTNB/operating-income)